GLP-2, for instance, has less to do with weight loss and more to do with promoting nutrient absorption and repairing the gut lining
The landscape of medical weight loss has just shifted dramatically
In studies of the effects of GLP-1, researchers estimate that 25 to 39 percent of the weight people lose on the drugs is muscle
Exenatide, MedlinePlus (2021) Dulaglutide, MedlinePlus (2023) Obesity in adolescents, The New England Journal of Medicine (2023) Nutrition and pubertal development, Indian Journal of Endocrinology and Metabolism (2014) GLP-1 receptor agonists and eating disorders, National Eating Disorder Association (n.d.) Facts about falls, Centers for Disease Control and Prevention (2024) Hypoglycemia in older people a less well recognized risk factor for frailty, Aging and Disease (2015) Ozempic, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Want the bigger research picture